Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2014 (2014), Article ID 983781, 6 pages
http://dx.doi.org/10.1155/2014/983781
Research Article

Clinical and Autoimmune Profile of Scleroderma Patients from Western India

1National Institute of Immunohaematology, Parel, Mumbai 400012, India
2Department of Medicine, King Edward Memorial Hospital, Parel, Mumbai 400012, India
3Institut National de la Santé et de la Recherche Médicale Unité 1138, Centre de Recherche des Cordeliers, UPMC Univ Paris 06, 75006 Paris 6, France

Received 6 August 2014; Revised 30 September 2014; Accepted 30 September 2014; Published 19 October 2014

Academic Editor: Kenneth C. Kalunian

Copyright © 2014 Vandana Pradhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Gorlova, J. E. Martin, B. Rueda et al., “Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome wide association strategy,” PLoS Genetics, vol. 7, no. 7, pp. 1–11, 2011. View at Google Scholar
  2. U. A. Walker, A. Tyndall, L. Czirjak et al., “Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trails and research give up database,” Annals of the Rheumatic Diseases, vol. 66, no. 6, pp. 754–763, 2007. View at Publisher · View at Google Scholar
  3. C. de Souza Müller, E. dos Santos Paiva, V. F. Azevedo, S. C. Radominski, and J. H. C. L. Filho, “Autoantibody profile and clinical correlation in a group of patients with systemic sclerosis in southern Brazil,” Revista Brasileira de Reumatologia, vol. 51, no. 4, pp. 314–324, 2011. View at Google Scholar · View at Scopus
  4. T. L. Skare, A. E. Fonseca, A. C. Luciano, and P. M. Azevedo, “Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil,” Anais Brasileiros de Dermatologia, vol. 86, no. 6, pp. 1075–1081, 2011. View at Google Scholar · View at Scopus
  5. M. E. Krzyszczak, Y. Li, S. J. Ross et al., “Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies,” Clinical Rheumatology, vol. 30, no. 10, pp. 1333–1339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. van den Hoogen, D. Khanna, J. Fransen et al., “2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative,” Arthritis & Rheumatology, vol. 65, no. 11, pp. 2737–2747, 2013. View at Google Scholar
  7. O. Nadashkevich, P. Davis, and M. J. Fritzler, “A proposal of criteria for the classification of systemic sclerosis,” Medical Science Monitor, vol. 10, no. 11, pp. CR615–CR621, 2004. View at Google Scholar · View at Scopus
  8. V. Steen, R. T. Domsic, M. Lucas, N. Fertig, and T. A. Medsger Jr., “A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis,” Arthritis and Rheumatism, vol. 64, no. 9, pp. 2986–2994, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Wielosz, O. Borys, I. Zychowska, and M. Majdan, “Gastrointestinal involvement in patients with systemic sclerosis,” Polskie Archiwum Medycyny Wewnetrznej, vol. 120, no. 4, pp. 132–136, 2010. View at Google Scholar · View at Scopus
  10. V. K. Sharma, T. Trilokraj, B. K. Khaitan, and S. M. Krishna, “Profile of systemic sclerosis in a tertiary care center in North India,” Indian Journal of Dermatology, Venereology and Leprology, vol. 72, no. 6, pp. 416–420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. G. V. Usha, R. G. Singh, S. S. Pande, A. Suri, and M. Seth, “Immunological Alterations in scleroderma,” Indian Academy of Clinical Medicine, vol. 2, no. 3, pp. 185–188, 2001. View at Google Scholar
  12. A. Kumar, A. N. Malaviya, S. C. Tiwari, R. R. Singh, and J. N. Pande, “Clinical and laboratory profile of systemic sclerosis in North India,” The Journal of the Association of Physicians of India, vol. 38, no. 10, pp. 765–768, 1990. View at Google Scholar · View at Scopus
  13. A. N. Chandrashekharan, V. Krishanmurthy, and R. Porkodi, “Spectrum of clinical and immunological features of systemic rheumatic diseases in a referral hospital in South India: progressive systemic scleoris,” Journal of Indian Rheumatism Association, vol. 2, no. 1, pp. 54–60, 1994. View at Google Scholar
  14. V. Krishnamurthy, R. Porkodi, S. Ramakrishnan et al., “Progressive systemic sclerosis in South India,” The Journal of the Association of Physicians of India, vol. 39, no. 3, pp. 254–257, 1991. View at Google Scholar · View at Scopus
  15. Y. Desai, M. A. Ghanekar, R. D. Siquera, and V. R. Joshi, “Renal involvement in scleroderma.,” The Journal of the Association of Physicians of India, vol. 38, no. 10, pp. 768–770, 1990. View at Google Scholar · View at Scopus
  16. R. Mierau, P. Moinzadeh, G. Riemekastern et al., “Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features,” Arthritis Research & Therapy, vol. 13, article R172, 2011. View at Publisher · View at Google Scholar
  17. S. R. Johnson, J. Fransen, D. Khanna et al., “Validation of potential classification criteria for systemic sclerosis,” Arthritis Care and Research, vol. 64, no. 3, pp. 358–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. L. V. Lage, J. F. de Carvalho, M. T. C. Caleiro et al., “Fluctuation of anti-endothelial cell antibody titers in mixed connective tissue disease,” Israel Medical Association Journal, vol. 14, no. 2, pp. 84–87, 2012. View at Google Scholar · View at Scopus
  19. A. E. Gliddon, C. J. Doré, J. Dunphy et al., “Antinuclear antibodies and clinical associations in a British cohort with limited cutaneous systemic sclerosis,” The Journal of Rheumatology, vol. 38, no. 4, pp. 702–705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Hesselstrand, A. Scheja, G. Q. Shen, A. Wiik, and A. Åkesson, “The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis,” Rheumatology, vol. 42, no. 4, pp. 534–540, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Servettaz, M. C. Tamby, P. Guilpain et al., “Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B),” Clinical Immunology, vol. 120, no. 2, pp. 212–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Mandai, Y. Arai, S. Hirasawa et al., “Anti-centromere antibody-positive subjects presenting with hypertensive emergency and renal dysfunction in the absence of skin manifestations: a variant of systemic sclerosis or a novel entity?” Internal Medicine, vol. 51, no. 12, pp. 1567–1572, 2012. View at Publisher · View at Google Scholar · View at Scopus